hydra+

active sensory powders /

Delivering the benefits of hyaluronic

acid with a powder-light finish
hydrated,
radiant and
soft
IMAGINE A MAKE-UP POWDER WITH A SOFT CREAMY TOUCH CAPABLE OF DELIVERING
MOISTURIZING BENEFITS! THIS IS PRECISELY WHAT ORGASOL® HYDRA+ DOES. IT EMPOWERS
ANHYDROUS FORMULAS AND BOOSTS THE HYDRATING POTENTIAL OF HYALURONIC ACID.

A UNIQUE DELIVERY SYSTEM

Orgasol ® powders are patented spheroidal
microspheres providing immediate sensory and
visual effects, binding for compact powders.
Being micro-porous, they can absorb high levels of
active substances and behave like micro-sponges
Orgasol® particle Orgasol® particle bursting with actives. They thus become easy- and
external porosity internal porosity ready-to-use delivery systems for various cosmetic
categories.
Their high compatibility with the skin and their
Orgasol® active
persistency at the skin’s surface allow continuous
powders mechanism release of the actives with closer and long-lasting
on strateum corneum contact with the stratum corneum and a synergistic
effect to maximize the delivery of actives.

HYALURONIC ACID,
A KEY HYDRATION FACTOR
A linear and water-soluble polysaccharide, hyaluronic
acid is an essential component of the dermis
and the epidermis. With its ability to trap water
molecules, it plays a key role in skin hydration and
water circulation. But it is also known to favor cell
mobility, tissue adhesion and proliferation.
Easy to incorporate into water-based formulas,
hyaluronic acid is however quite difficult to use
in anhydrous media such as sticks or powders.
one ingredient,
multiple benefits
delivering deep and efficient hydration
Active make up / Moisturizing / Anti-aging /
Reduce fine lines and wrinkles / Restore elacticity /
Skin smoothness, etc.
Instant moisturizing powder
The moisturizing action of Orgasol® Hydra+ has
been evaluated through a full clinical - instrumental First results
study and self-assessment by the volunteers. Skin after 2 hrs
properties can be measured using various accurate
5
and effective methods such as corneometry,

variations vs untreated
4
suction/elongation method or image analysis.

control (%)
3
Consistent short- and long-term results were obtained
2
on various face colour applications: hot-poured
1
fondation, lip gloss and compact powder.
0
1hr 2hrs
Placebo Orgasol Hydra+
®

Corneometry – Short-term and long-term increase of the hydration

index with a face powder.

Improve skin elasticity Plump the lips

up to 20% +12% after

in 30 days 30 days

13 12
variations vs untreated
variations vs untreated

11 10
control (%)

9 8
control (%)

7 6
5
4
3
1 2
0 0
7 days 15 days 30 days 7 days 15 days 30 days
Placebo Orgasol® Hydra+ Placebo Orgasol® Hydra+

Suction/elongation method – improvement of the biomechanical Image analysis: short-term and long-term improvement of lip
properties of the skin with a hot-poured foundation. volume with a lip gloss.

achieving optical enhancing

perfection
Instant blurring or Soft focus effect /
Anti-wrinkle / Even complexion / Shine control
Due to their intrinsic physical properties, Orgasol
active powders also deliver instant and long-lasting
optical blurring effect and significantly decrease
the length, surface and volume of wrinkles.
the sensory
experience
Creamy / Powder finish / Long lasting wear
®
In parallel to their functional properties, Orgasol®
active powders transform the sensory experience
of your formulation with a signature touch.
product characteristics

Arkema France - A French «Société Anonyme», registered with the Commercial and Companies Register of Nanterre (France) under number 319 632 790.
INCI (EU): NYLON-12 (and) AQUA (and) SODIUM HYALURONATE (and) BENZYL
Name
ALCOHOL (and) DEHYDROACETIC ACID
Aspect White powder (Visual)
Average particle size Approximately 5 microns (ISO 13319)
Active content Sodium hyaluronate aqueous solution >30% (Arkema*)
Bacteriology <100 cfu/g (ISO 21149)
Microbiology
Mycology <100 cfu/g (Arkema*)
*Arkema analytical methods are available upon request.

READY-TO-USE INGREDIENT FOR EASY AND SIMPLIFIED PROCESSING,

ESPECIALLY IN COLOR COSMETICS AND ANHYDROUS FORMS.

DIRCOM 4402E/03.2015/3 - PASpe. Picture credits: © Shutterstock. Agence Re-Source.

Dosage 2 - 5%
W/O, W/S emulsions, add after emulsification. Anhydrous: stick, powder, hot-poured
Formulations
foundation.
Skin care (lip care, alphabet cream, primer), make-up (compact & loose powder, foundation,
Applications
concealer, lipstick / lipgloss, active make-up).

PACKAGING: 5 kg DRUMS

The statements, technical information and recommendations contained herein are believed to be accurate as of the date hereof. Since the conditions and methods
of use of the product and of the information referred to herein are beyond our control, ARKEMA expressly disclaims any and all liability as to any results obtained or
arising from any use of the product or reliance on such information; NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTA-
BILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE GOODS DESCRIBED OR THE INFORMATION PROVIDED HEREIN. The
information provided herein relates only to the specific product designated and may not be applicable when such product is used in combination with other materials
or in any process. The user should thoroughly test any application before commercialization. Nothing contained herein constitutes a license to practice under any
patent and it should not be construed as an inducement to infringe any patent and the user is advised to take appropriate steps to be sure that any proposed use of
the product will not result in patent infringement. See SDS for Health & Safety Considerations.
Arkema has implemented a Medical Policy regarding the use of Arkema products in Medical Device applications that are in contact with the body or circulating
bodily fluids (http://www.arkema.com/en/social-responsibility/responsible-product-management/medical-device-policy/index.html). Arkema has designated Medical
grades to be used for such Medical Device applications. Products that have not been designated as Medical grades are not authorized by Arkema for use in Medical
Device applications that are in contact with the body or circulating bodily fluids. In addition, Arkema strictly prohibits the use of any Arkema products in Medical Device
applications that are implanted in the body or in contact with bodily fluids or tissues for more than 30 days. The Arkema trademarks and the Arkema name shall not
be used in conjunction with customers’ medical devices, including without limitation, permanent or temporary implantable devices, and customers shall not represent
to anyone else that Arkema allows, endorses or permits the use of Arkema products in such medical devices.
It is the sole responsibility of the manufacturer of the medical device to determine the suitability (including biocompatibility) of all raw materials, products and compo-
nents, including any medical grade Arkema products, in order to ensure that the final end-use product is safe for its end use; performs or functions as intended; and
complies with all applicable legal and regulatory requirements (FDA or other national drug agencies). It is the sole responsibility of the manufacturer of the medical
device to conduct all necessary tests and inspections and to evaluate the medical device under actual end-use requirements and to adequately advise and warn
purchasers, users, and/or learned intermediaries (such as physicians) of pertinent risks and fulfill any postmarket surveillance obligations. Any decision regarding the
appropriateness of a particular Arkema material in a particular medical device should be based on the judgment of the manufacturer, seller, the competent authority,
and the treating physician.

Headquarters: Arkema France

Specialty Polyamides
420, rue d’Estienne d’Orves
92705 Colombes Cedex - France
arkema.com
info.orgasol@arkema.com Tel : 33 (0)1 49 00 80 80
orgasolcosmetics.com Fax : 33 (0)1 49 00 83 96